Andrea Kerkhoff
University Hospital Münster(DE)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, Acute Myeloid Leukemia Research
Most-Cited Works
- → Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma(2020)163 cited
- → PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial(2021)156 cited
- → Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study(2017)121 cited
- → Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network(2024)116 cited
- → Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials(2016)112 cited
- → Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer(2019)107 cited
- → Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas(2021)89 cited
- → Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial(2022)82 cited
- → Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia(1998)62 cited
- → Treating Anemia in the Preanesthesia Assessment Clinic: Results of a Retrospective Evaluation(2018)54 cited